PCH
IBB icon

PGIM Custom Harvest’s iShares Biotechnology ETF IBB Stock Holding History

PGIM Custom Harvest’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,196
Closed -$290K – 248
2024
Q4 		$290K Buy
2,196
+384
+21% +$54K 0.01% 204
2024
Q3 		$264K Buy
1,812
+108
+6% +$15.6K 0.01% 201
2024
Q2 		$234K Sell
1,704
-65
-4% -$8.68K 0.01% 204
2024
Q1 		$243K Buy
1,769
+167
+10% +$22.8K 0.01% 188
2023
Q4 		$218K Sell
1,602
-468
-23% -$57.1K 0.01% 179
2023
Q3 		$253K Buy
2,070
+82
+4% +$10.4K 0.01% 156
2023
Q2 		$252K Hold
1,988
– – 0.01% 154
2023
Q1 		$257K Hold
1,988
– – 0.01% 173
2022
Q4 		$261K Buy
+1,988
New +$257K 0.01% 179

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

PGIM Custom Harvest's IBB Position: Q1 2025 in Review

PGIM Custom Harvest sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 2,196 shares — an estimated $290K sold.

PGIM Custom Harvest first reported a position in IBB in Q4 2022 and held it in 9 quarters. The position peaked at $290K in Q4 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • PGIM Custom Harvest reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • PGIM Custom Harvest sold 2,196 iShares Biotechnology ETF shares in Q1 2025, an estimated $290K.
  • PGIM Custom Harvest first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 9 quarters.
  • PGIM Custom Harvest's iShares Biotechnology ETF position peaked at $290K in Q4 2024.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on PGIM Custom Harvest's 13F filing for Q1 2025, filed 14 May 2025.